Latest Insider Transactions at Procter & Gamble CO (PG)
This section provides a real-time view of insider transactions for Procter & Gamble CO (PG). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of PROCTER & GAMBLE Co to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of PROCTER & GAMBLE Co's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 16
2022
|
Jennifer L. Davis CEO - Health Care |
BUY
Grant, award, or other acquisition
|
Direct |
19,021
+31.95%
|
-
|
|
Aug 16
2022
|
Gary A Coombe CEO - Grooming |
BUY
Grant, award, or other acquisition
|
Direct |
28,552
+40.23%
|
-
|
|
Aug 16
2022
|
Moses Victor Javier Aguilar Chf Rsch, Dev & Innov Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,527
+23.41%
|
-
|
|
Aug 16
2022
|
Ma. Fatima Francisco CEO - Baby, Fem & Family Care |
SELL
Open market or private sale
|
Direct |
58,538
-98.28%
|
$8,722,162
$149.5 P/Share
|
|
Aug 16
2022
|
Ma. Fatima Francisco CEO - Baby, Fem & Family Care |
BUY
Exercise of conversion of derivative security
|
Direct |
58,538
+49.57%
|
$4,683,040
$80.29 P/Share
|
|
Aug 15
2022
|
Sundar G. Raman CEO-Fabric & Home Care |
SELL
Open market or private sale
|
Direct |
5,181
-56.42%
|
$766,788
$148.0 P/Share
|
|
Aug 15
2022
|
Sundar G. Raman CEO-Fabric & Home Care |
BUY
Exercise of conversion of derivative security
|
Direct |
5,181
+36.07%
|
$440,385
$85.13 P/Share
|
|
Aug 15
2022
|
Ma. Fatima Francisco CEO - Baby, Fem & Family Care |
SELL
Open market or private sale
|
Direct |
17,975
-94.61%
|
$2,660,300
$148.0 P/Share
|
|
Aug 15
2022
|
Ma. Fatima Francisco CEO - Baby, Fem & Family Care |
BUY
Exercise of conversion of derivative security
|
Direct |
17,975
+48.61%
|
$1,527,875
$85.13 P/Share
|
|
Aug 15
2022
|
Jon R Moeller Chairman, President and CEO |
SELL
Open market or private sale
|
Indirect |
23,943
-41.02%
|
$3,519,621
$147.86 P/Share
|
|
Aug 15
2022
|
Jon R Moeller Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
23,943
+29.09%
|
$1,867,554
$78.52 P/Share
|
|
Aug 12
2022
|
Jon R Moeller Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
169,365
-50.69%
|
$24,727,290
$146.56 P/Share
|
|
Aug 12
2022
|
Jon R Moeller Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
169,365
+33.64%
|
$13,210,470
$78.52 P/Share
|
|
Aug 11
2022
|
Mary Theresa Grabowski Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
16,000
-78.72%
|
$2,352,000
$147.0 P/Share
|
|
Aug 11
2022
|
Mary Theresa Grabowski Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,000
+44.05%
|
$1,360,000
$85.13 P/Share
|
|
Aug 08
2022
|
Ma. Fatima Francisco CEO - Baby, Fem & Family Care |
SELL
Open market or private sale
|
Direct |
4,000
-79.6%
|
$584,000
$146.0 P/Share
|
|
Aug 04
2022
|
R. Alexandra Keith CEO - Beauty |
BUY
Grant, award, or other acquisition
|
Indirect |
178
+2.23%
|
-
|
|
Aug 04
2022
|
Matthew W. Janzaruk SVP - Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
71
+5.19%
|
-
|
|
Aug 03
2022
|
Ma. Fatima Francisco CEO - Baby, Fem & Family Care |
SELL
Open market or private sale
|
Direct |
2,000
-28.47%
|
$290,000
$145.0 P/Share
|
|
Jul 07
2022
|
Sundar G. Raman CEO-Fabric & Home Care |
SELL
Open market or private sale
|
Direct |
1,599
-28.55%
|
$231,855
$145.12 P/Share
|
|
Jun 14
2022
|
Patricia A Woertz Director |
BUY
Grant, award, or other acquisition
|
Direct |
281
+0.69%
|
-
|
|
Jun 14
2022
|
Bertrand Marc Allen Director |
BUY
Grant, award, or other acquisition
|
Direct |
225
+7.99%
|
-
|
|
Jun 14
2022
|
Angela F Braly Director |
BUY
Grant, award, or other acquisition
|
Direct |
262
+0.52%
|
-
|
|
Jun 14
2022
|
Joseph Jimenez Director |
BUY
Grant, award, or other acquisition
|
Direct |
299
+1.2%
|
-
|
|
Jun 14
2022
|
Christopher J Kempczinski Director |
BUY
Grant, award, or other acquisition
|
Direct |
225
+10.95%
|
-
|
|
Jun 14
2022
|
Terry J Lundgren Director |
BUY
Grant, award, or other acquisition
|
Direct |
271
+0.82%
|
-
|
|
Jun 14
2022
|
Christine M Mc Carthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
225
+3.16%
|
-
|
|
Apr 27
2022
|
Jon R Moeller Chairman, President and CEO |
SELL
Open market or private sale
|
Indirect |
81
-0.23%
|
$12,879
$159.3 P/Share
|
|
Apr 26
2022
|
Matthew W. Janzaruk SVP - Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
334
-21.51%
|
$54,108
$162.43 P/Share
|
|
Apr 25
2022
|
David S Taylor Executive Chairman |
SELL
Open market or private sale
|
Direct |
30,000
-10.57%
|
$4,860,000
$162.83 P/Share
|
|
Apr 25
2022
|
David S Taylor Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+9.56%
|
$2,640,000
$88.06 P/Share
|
|
Apr 21
2022
|
R. Alexandra Keith CEO - Beauty |
SELL
Open market or private sale
|
Indirect |
1,335
-14.99%
|
$217,605
$163.5 P/Share
|
|
Apr 21
2022
|
R. Alexandra Keith CEO - Beauty |
SELL
Open market or private sale
|
Direct |
6,854
-16.46%
|
$1,117,202
$163.5 P/Share
|
|
Apr 21
2022
|
David S Taylor Executive Chairman |
SELL
Open market or private sale
|
Direct |
60,000
-19.11%
|
$9,840,000
$164.52 P/Share
|
|
Apr 21
2022
|
David S Taylor Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
60,000
+16.05%
|
$5,280,000
$88.06 P/Share
|
|
Apr 21
2022
|
Ma. Fatima Francisco CEO - Baby, Fem & Family Care |
SELL
Open market or private sale
|
Direct |
18,000
-45.84%
|
$2,952,000
$164.33 P/Share
|
|
Apr 21
2022
|
Ma. Fatima Francisco CEO - Baby, Fem & Family Care |
BUY
Exercise of conversion of derivative security
|
Direct |
16,000
+41.0%
|
$1,360,000
$85.13 P/Share
|
|
Mar 08
2022
|
Bertrand Marc Allen Director |
BUY
Grant, award, or other acquisition
|
Direct |
171
+6.78%
|
-
|
|
Mar 08
2022
|
Angela F Braly Director |
BUY
Grant, award, or other acquisition
|
Direct |
205
+0.41%
|
-
|
|
Mar 08
2022
|
Joseph Jimenez Director |
BUY
Grant, award, or other acquisition
|
Direct |
239
+0.98%
|
-
|
|
Mar 08
2022
|
Christopher J Kempczinski Director |
BUY
Grant, award, or other acquisition
|
Direct |
171
+9.68%
|
-
|
|
Mar 08
2022
|
Terry J Lundgren Director |
BUY
Grant, award, or other acquisition
|
Direct |
213
+0.65%
|
-
|
|
Mar 08
2022
|
Christine M Mc Carthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
171
+2.51%
|
-
|
|
Mar 08
2022
|
Patricia A Woertz Director |
BUY
Grant, award, or other acquisition
|
Direct |
222
+0.55%
|
-
|
|
Mar 01
2022
|
R. Alexandra Keith CEO - Beauty |
SELL
Open market or private sale
|
Indirect |
1,054
-10.58%
|
$161,262
$153.51 P/Share
|
|
Mar 01
2022
|
R. Alexandra Keith CEO - Beauty |
SELL
Open market or private sale
|
Direct |
5,777
-12.18%
|
$883,881
$153.51 P/Share
|
|
Mar 01
2022
|
R. Alexandra Keith CEO - Beauty |
BUY
Grant, award, or other acquisition
|
Indirect |
3,262
+24.67%
|
-
|
|
Mar 01
2022
|
Andre Schulten Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,335
-5.03%
|
$204,255
$153.51 P/Share
|
|
Mar 01
2022
|
Carolyn M Tastad CEO - Health Care |
SELL
Open market or private sale
|
Direct |
3,730
-11.7%
|
$570,690
$153.51 P/Share
|
|
Mar 01
2022
|
David S Taylor Executive Chairman |
SELL
Open market or private sale
|
Direct |
12,953
-4.85%
|
$1,981,809
$153.51 P/Share
|